Citations (46)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Parisa Shamshiripour, Mehdi Nikoobakht, Zahra Mansourinejad, Davoud Ahmadvand & Mahzad Akbarpour. (2022) A comprehensive update to Dendritic Cell therapy for glioma: a systematic review and meta-analysis. Expert Review of Vaccines 21:4, pages 513-531.
Read now
Read now
Articles from other publishers (45)
Smrithi Padmakumar & Mansoor M. Amiji. (2023) Long-acting therapeutic delivery systems for the treatment of gliomas. Advanced Drug Delivery Reviews 197, pages 114853.
Crossref
Crossref
Matías Daniel Caverzán, Lucía Beaugé, Paula Martina Oliveda, Bruno Cesca González, Eugenia Micaela Bühler & Luis Exequiel Ibarra. (2023) Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies. Brain Sciences 13:4, pages 542.
Crossref
Crossref
Liang Rong, Ni Li & Zhenzhen Zhang. (2022) Emerging therapies for glioblastoma: current state and future directions. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Crossref
Jieting Liu, Hongrui Zhang, Jingyun Zhang, Zhitong Bing, Yingbin Wang, Qiao Li & Kehu Yang. (2021) Identification of robust diagnostic and prognostic gene signatures in different grades of gliomas: a retrospective study. PeerJ 9, pages e11350.
Crossref
Crossref
Li Hu, Zhibin Han, Xingbo Cheng, Sida Wang, Yumeng Feng & Zhiguo Lin. (2021) Expression Profile Analysis Identifies a Novel Seven Immune-Related Gene Signature to Improve Prognosis Prediction of Glioblastoma. Frontiers in Genetics 12.
Crossref
Crossref
Jen-Fu Hsu, Shih-Ming Chu, Chen-Chu Liao, Chao-Jan Wang, Yi-Shan Wang, Mei-Yin Lai, Hsiao-Chin Wang, Hsuan-Rong Huang & Ming-Horng Tsai. (2021) Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update. Cancers 13:2, pages 195.
Crossref
Crossref
Kai-Fu Chang, Xiao-Fan Huang, Jinghua Tsai Chang, Ya-Chih Huang, Wei-Syuan Lo, Chih-Yen Hsiao & Nu-Man Tsai. (2020) Cedrol, a Sesquiterpene Alcohol, Enhances the Anticancer Efficacy of Temozolomide in Attenuating Drug Resistance via Regulation of the DNA Damage Response and MGMT Expression. Journal of Natural Products 83:10, pages 3021-3029.
Crossref
Crossref
Nneoma Adaku, Hyun Bong Park, Daniel J. Spakowicz, Meetu Kaushik Tiwari, Scott A. Strobel, Jason M. Crawford & Faye A. Rogers. (2020) A DNA Repair Inhibitor Isolated from an Ecuadorian Fungal Endophyte Exhibits Synthetic Lethality in PTEN-Deficient Glioblastoma. Journal of Natural Products 83:6, pages 1899-1908.
Crossref
Crossref
Yilei Xiao, Zipeng Zhu, Jianxiong Li, Jie Yao, Haitao Jiang, Ran Ran, Xueyuan Li & Zhiqiang Li. (2020) Expression and prognostic value of long non-coding RNA H19 in glioma via integrated bioinformatics analyses. Aging 12:4, pages 3407-3430.
Crossref
Crossref
Cristina Maccallini, Marialucia Gallorini, Amelia Cataldi & Rosa Amoroso. (2020) Targeting iNOS As a Valuable Strategy for the Therapy of Glioma. ChemMedChem 15:4, pages 339-344.
Crossref
Crossref
Jake Mazur, Kislay Roy, Sarah Shigdar & Jagat R. Kanwar. 2020. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents. Advances and Avenues in the Development of Novel Carriers for Bioactives and Biological Agents
383
422
.
Xiao Wei, Susanne Hain, Lynn Hartmann, Stefan Hirzebruch & Hojjat Ahmadzadehfar. (2019) Dual Imaging With 68Ga-DOTATOC and 18F-FDG PET for Planning and Follow-up of PRRT in Combination With Temozolomide Treatment in a Patient With a Metastatic Neuroendocrine Tumor. Clinical Nuclear Medicine 44:6, pages 480-482.
Crossref
Crossref
Shuguang Zuo, Xinhong Zhang & Liping Wang. (2019) A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma. Scientific Reports 9:1.
Crossref
Crossref
Jonathan Fahey & Albert Girotti. (2019) Nitric Oxide Antagonism to Anti-Glioblastoma Photodynamic Therapy: Mitigation by Inhibitors of Nitric Oxide Generation. Cancers 11:2, pages 231.
Crossref
Crossref
Israel López-Valero, Sofía Torres, María Salazar-Roa, Elena García-Taboada, Sonia Hernández-Tiedra, Manuel Guzmán, Juan M. Sepúlveda, Guillermo Velasco & Mar Lorente. (2018) Optimization of a preclinical therapy of cannabinoids in combination with temozolomide against glioma. Biochemical Pharmacology 157, pages 275-284.
Crossref
Crossref
Alexandra Y. Tsidulko, Cynthia Bezier, Gabin de La Bourdonnaye, Anastasia V. Suhovskih, Tatiana M. Pankova, Galina M. Kazanskaya, Svetlana V. Aidagulova & Elvira V. Grigorieva. (2018) Conventional Anti-glioblastoma Chemotherapy Affects Proteoglycan Composition of Brain Extracellular Matrix in Rat Experimental Model in vivo. Frontiers in Pharmacology 9.
Crossref
Crossref
Wanyin Chen, Leonel Nguekeu Zebaze, Jihu Dong, Laëtitia Chézeau, Perrine Inquimbert, Sylvain Hugel, Songlin Niu, Fréderic Bihel, Emmanuel Boutant, Eléonore Réal, Pascal Villa, Marie-Pierre Junier, Hervé Chneiweiss, Marcel Hibert, Jacques Haiech, Marie-Claude Kilhoffer & Maria Zeniou. (2018) WNK1 kinase and its partners Akt, SGK1 and NBC-family Na+/HCO3− cotransporters are potential therapeutic targets for glioblastoma stem-like cells linked to Bisacodyl signaling. Oncotarget 9:43, pages 27197-27219.
Crossref
Crossref
D. M. Tiek, J. D. Rone, G. T. Graham, E. L. Pannkuk, B. R. Haddad & R. B. Riggins. (2018) Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma. Scientific Reports 8:1.
Crossref
Crossref
Pedro R. Lowenstein & Maria G. Castro. (2018) Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients. Clinical Immunology 189, pages 43-51.
Crossref
Crossref
Maria J. Ramalho, Manuel A.N. Coelho & Maria C. Pereira. 2018. Design and Development of New Nanocarriers. Design and Development of New Nanocarriers
687
722
.
Beverly Teicher & Herbert B. Newton. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
59
73
.
Vera Miranda-Gonçalves, Diana Cardoso-Carneiro, Inês Valbom, Fernanda Paula Cury, Viviane Aline Silva, Sara Granja, Rui M. Reis, Fátima Baltazar & Olga Martinho. (2017) Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells. Oncotarget 8:61, pages 103657-103670.
Crossref
Crossref
Yung-Chih Kuo, Chia-Hao Lee & Rajendiran Rajesh. (2017) Recent advances in the treatment of glioblastoma multiforme by inhibiting angiogenesis and using nanocarrier systems. Journal of the Taiwan Institute of Chemical Engineers 77, pages 30-40.
Crossref
Crossref
Kuo-Chen Wei, Chia-Yuan Chen, Li-Ying Feng, Wei-Tzu Huang, Chia-Hua Chen, Peng-Wei Hsu, Kai Wang, Leroy E. Hood & Leslie Y. Chen. (2017) The rs16906252:C>T SNP is not associated with increased overall survival or temozolomide response in a Han-Chinese glioma cohort. PLOS ONE 12:6, pages e0178842.
Crossref
Crossref
Thomas Efferth, Ursula Schöttler, Sanjeev Krishna, Peter Schmiedek, Frederik Wenz & Frank A. Giordano. (2016) Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature. Archives of Toxicology 91:4, pages 1833-1846.
Crossref
Crossref
Liang Xue, Yi Wang, Shuyuan Yue & Jianning Zhang. (2016) The expression of miRNA-221 and miRNA-222 in gliomas patients and their prognosis. Neurological Sciences 38:1, pages 67-73.
Crossref
Crossref
Zhen Zhang, Chunliu Li, Li Shang, Yuejuan Zhang, Rong Zou, Yan Zhan & Benjun Bi. (2016) Sulforaphane induces apoptosis and inhibits invasion in U251MG glioblastoma cells. SpringerPlus 5:1.
Crossref
Crossref
Aleksei A. Stepanenko, Svitlana V. Andreieva, Kateryna V. Korets, Dmytro O. Mykytenko, Vladimir P. Baklaushev, Nataliya L. Huleyuk, Oksana A. Kovalova, Kateryna V. Kotsarenko, Vladimir P. Chekhonin, Yegor S. Vassetzky, Stanislav S. Avdieiev & Vladimir V. Dmitrenko. (2016) Temozolomide promotes genomic and phenotypic changes in glioblastoma cells. Cancer Cell International 16:1.
Crossref
Crossref
Theresa Pesch, Harald Schuhwerk, Philippe Wyrsch, Timo Immel, Wilhelm Dirks, Alexander Bürkle, Thomas Huhn & Sascha Beneke. (2016) Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage. BMC Cancer 16:1.
Crossref
Crossref
Tian Tian, Ma Mingyi, Xia Qiu & Yang Qiu. (2016) MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma. Oncotarget 7:48, pages 79584-79595.
Crossref
Crossref
Tina Sehm, Manfred Rauh, Kurt Wiendieck, Michael Buchfelder, IIker Y. Eyüpoglu & Nicolai E. Savaskan. (2016) Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis. Oncotarget 7:46, pages 74630-74647.
Crossref
Crossref
Martin Uhl, Stefan Schwab & Thomas Efferth. (2016) Fatal Liver and Bone Marrow Toxicity by Combination Treatment of Dichloroacetate and Artesunate in a Glioblastoma Multiforme Patient: Case Report and Review of the Literature. Frontiers in Oncology 6.
Crossref
Crossref
Sara Ferluga, Carla Maria Lema Tomé, Denise Mazess Herpai, Ralph D'Agostino & Waldemar Debinski. (2016) Simultaneous targeting of Eph receptors in glioblastoma. Oncotarget 7:37, pages 59860-59876.
Crossref
Crossref
Mahalingam Rajamanickam Vijayakumar, Kiran Yellappa Vajanthri, Chelladurai Karthikeyan Balavigneswaran, Sanjeev Kumar Mahto, Nira Mishra, Madaswamy S. Muthu & Sanjay Singh. (2016) Pharmacokinetics, biodistribution, in vitro cytotoxicity and biocompatibility of Vitamin E TPGS coated trans resveratrol liposomes. Colloids and Surfaces B: Biointerfaces 145, pages 479-491.
Crossref
Crossref
Jin-feng Zhang, Yao Chen, Guo-shi Lin, Jian-dong Zhang, Wen-long Tang, Jian-huang Huang, Jin-shou Chen, Xing-fu Wang & Zhi-xiong Lin. (2016) High IFIT1 expression predicts improved clinical outcome, and IFIT1 along with MGMT more accurately predicts prognosis in newly diagnosed glioblastoma. Human Pathology 52, pages 136-144.
Crossref
Crossref
Jun Feng, Peng-Fei Yan, Hong-yang Zhao, Fang-Cheng Zhang, Wo-Hua Zhao & Min Feng. (2016) Inhibitor of Nicotinamide Phosphoribosyltransferase Sensitizes Glioblastoma Cells to Temozolomide via Activating ROS/JNK Signaling Pathway. BioMed Research International 2016, pages 1-11.
Crossref
Crossref
D. Carradori, A. Gaudin, D. Brambilla & K. Andrieux. 2016. Nanotechnology and the Brain. Nanotechnology and the Brain
73
113
.
Chen-Xing Wu, Guo-Shi Lin, Zhi-Xiong Lin, Jian-Dong Zhang, Shui-Yuan Liu & Chang-Fu Zhou. (2015) Peritumoral edema shown by MRI predicts poor clinical outcome in glioblastoma. World Journal of Surgical Oncology 13:1.
Crossref
Crossref
YU-CHENG CHOU, MENG-YA CHANG, MEI-JEN WANG, FU-SHUN YU, HSIN-CHUNG LIU, TOMOR HARNOD, CHIH-HUANG HUNG, HSU-TUNG LEE & JING-GUNG CHUNG. (2015) PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression. Oncology Reports 34:5, pages 2489-2496.
Crossref
Crossref
CHEN-XING WU, GUO-SHI LIN, ZHI-XIONG LIN, JIAN-DONG ZHANG, LONG CHEN, SHUI-YUAN LIU, WEN-LONG TANG, XIAN-XIN QIU & CHANG-FU ZHOU. (2015) Peritumoral edema on magnetic resonance imaging predicts a poor clinical outcome in malignant glioma. Oncology Letters 10:5, pages 2769-2776.
Crossref
Crossref
Sandra G. Boccard, Sandie V. Marand, Sandra Geraci, Laurie Pycroft, François R. Berger & Laurent A. Pelletier. (2015) Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study. Oncotarget 6:30, pages 29456-29468.
Crossref
Crossref
Olga Martinho, Luis Eduardo Zucca & Rui Manuel Reis. (2015) AXL as a modulator of sunitinib response in glioblastoma cell lines. Experimental Cell Research 332:1, pages 1-10.
Crossref
Crossref
Yu-Cheng Chou, Meng-Ya Chang, Mei-Jen Wang, Tomor Harnod, Chih-Huang Hung, Hsu-Tung Lee, Chiung-Chyi Shen & Jing-Gung Chung. (2015) PEITC induces apoptosis of Human Brain Glioblastoma GBM8401 Cells through the extrinsic- and intrinsic -signaling pathways. Neurochemistry International 81, pages 32-40.
Crossref
Crossref
Kyle T. Householder, Danielle M. DiPerna, Eugene P. Chung, Gregory M. Wohlleb, Harshil D. Dhruv, Michael E. Berens & Rachael W. Sirianni. (2015) Intravenous delivery of camptothecin-loaded PLGA nanoparticles for the treatment of intracranial glioma. International Journal of Pharmaceutics 479:2, pages 374-380.
Crossref
Crossref
Guo-Shi Lin, Li-Juan Yang, Xing-Fu Wang, Yu-Peng Chen, Wen-Long Tang, Long Chen & Zhi-Xiong Lin. (2014) STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma. Medical Oncology 31:4.
Crossref
Crossref